{"schema_version":"secwatch.filing_event.v1","accession":"0001671284-24-000032","form_type":"8-K","ticker":null,"cik":"0001671284","company_name":"NeueHealth, Inc.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.510692+00:00","generated_at":"2026-06-02T10:50:52.922955+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NeueHealth Q1 net income $5.7M vs loss of $53.9M YoY; adj. EBITDA $2.5M; revenue $245M","bullets":["Revenue of $245.1M, down 18% YoY from $300.6M; net income from continuing ops of $5.7M vs loss of $53.9M.","Adjusted EBITDA of $2.5M in Q1’24 vs negative $5.7M YoY; 2024 adj. EBITDA guidance maintained at $15-25M.","Value-Based Consumers served 360,000 (down 3.5% YoY); Enablement Services Lives surged to 109,000 from 27,000.","2014 full-year revenue guidance ~$1B with NeueCare segment $310-320M and NeueSolutions $690-700M.","Adjusted Operating Cost Ratio guided at 15-16% (ex-corporate) and 19-20% (inclusive) for 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001671284-24-000032","json":"https://secwatch.observer/filing/0001671284-24-000032.json","markdown":"https://secwatch.observer/filing/0001671284-24-000032.md","text":"https://secwatch.observer/filing/0001671284-24-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671284/000167128424000032/0001671284-24-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671284/000167128424000032/bhg-20240508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T10:50:52.922955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e9587fbb95a1bcfa5bf584706b797a2e6eddb63","claim":"NeueHealth, Inc. reported first quarter ended March 31, 2024 results: revenue $245,095, net income $5,688. Guidance reaffirmed.","evidence_excerpt":"Metrics Value-Based Consumers served 360,000 373,000 Enablement Services Lives 109,000 27,000 Three Months Ended ($ in thousands) March 31, 2024 2023 Financial Metrics Revenue $ 245,095 $ 300,550 Net Income (Loss) from Continuing Operations $ 5,688 $ (53,918) Adjusted EBITDA (non-GAAP) $ 2,529 $ (5,743) See the table at the end of this release for additional","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671284/000167128424000032/0001671284-24-000032-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$245,095"},{"label":"Net income","value":"$5,688"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}